Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000729906 | SCV000857604 | uncertain significance | not provided | 2017-11-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004678806 | SCV005168242 | uncertain significance | Inborn genetic diseases | 2024-04-08 | criteria provided, single submitter | clinical testing | The c.1663T>C (p.F555L) alteration is located in exon 14 (coding exon 13) of the TCIRG1 gene. This alteration results from a T to C substitution at nucleotide position 1663, causing the phenylalanine (F) at amino acid position 555 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001279345 | SCV001466433 | uncertain significance | Autosomal recessive osteopetrosis 1 | 2020-04-16 | no assertion criteria provided | clinical testing |